This inventor holds 1 USPTO granted patent. Top assignee: Ribon Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Inventor Xin He
Introduction
Xin He is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Xin He holds a patent for solid forms of a PARP7 inhibitor. The patent, titled "Solid forms of a PARP7 inhibitor," relates to the compound 5-[[[2S]-1-(3-oxo-3-[4-[5-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl]propoxy)propan-2-yl]amino]-4-(trifluoromethyl)-2,3-dihydropyridazin-3-one, and its salts. This invention is particularly valuable as it provides methods of preparation for the inhibitor, which is useful in the treatment of cancer. Xin He has 1 patent to his name.
Career Highlights
Xin He is currently employed at Ribon Therapeutics, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of Xin He's coworkers include Melissa Marie Vasbinder and Laurie B Schenkel. Their collaboration contributes to the dynamic environment at Ribon Therapeutics, Inc., fostering innovation and progress in cancer treatment.
Conclusion
Xin He's contributions to the field of pharmaceuticals, particularly through his patent for a PARP7 inhibitor, highlight his role as an influential inventor. His work at Ribon Therapeutics, Inc. continues to pave the way for advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile